These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30311384)

  • 21. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.
    Allanson JE
    Am J Med Genet A; 2016 Oct; 170(10):2570-7. PubMed ID: 27155212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral muscle weakness in RASopathies.
    Stevenson DA; Allen S; Tidyman WE; Carey JC; Viskochil DH; Stevens A; Hanson H; Sheng X; Thompson BA; Okumura MJ; Reinker K; Johnson B; Rauen KA
    Muscle Nerve; 2012 Sep; 46(3):394-9. PubMed ID: 22907230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The heart in RASopathies.
    Delogu AB; Limongelli G; Versacci P; Adorisio R; Kaski JP; Blandino R; Maiolo S; Monda E; Putotto C; De Rosa G; Chatfield KC; Gelb BD; Calcagni G
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):440-451. PubMed ID: 36408797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.
    Leung GKC; Luk HM; Tang VHM; Gao WW; Mak CCY; Yu MHC; Wong WL; Chu YWY; Yang WL; Wong WHS; Ma ACH; Leung AYH; Jin DY; Chan KYK; Allanson J; Lo IFM; Chung BHY
    Sci Rep; 2018 Feb; 8(1):2421. PubMed ID: 29402968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignancy in Noonan syndrome and related disorders.
    Smpokou P; Zand DJ; Rosenbaum KN; Summar ML
    Clin Genet; 2015 Dec; 88(6):516-22. PubMed ID: 25683281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RASopathies are associated with a distinct personality profile.
    Bizaoui V; Gage J; Brar R; Rauen KA; Weiss LA
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):434-446. PubMed ID: 29659143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RASopathies: Biology, genetics and therapeutic options.
    Longo JF; Carroll SL
    Adv Cancer Res; 2022; 153():305-341. PubMed ID: 35101235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antenatal diagnosis of cardio-facio-cutaneous syndrome: Prenatal characteristics and contribution of fetal facial dysmorphic signs in utero. About a case and review of literature.
    Biard JM; Steenhaut P; Bernard P; Race V; Sznajer Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():232-241. PubMed ID: 31336229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurodevelopmental Aspects of RASopathies.
    Kim YE; Baek ST
    Mol Cells; 2019 Jun; 42(6):441-447. PubMed ID: 31250618
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
    Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
    Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.
    Kratz CP; Rapisuwon S; Reed H; Hasle H; Rosenberg PS
    Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):83-9. PubMed ID: 21500339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Craniosynostosis is a feature of Costello syndrome.
    Weaver KN; Care M; Wakefield E; Zarate YA; Skoch J; Gripp KW; Prada CE
    Am J Med Genet A; 2022 Apr; 188(4):1280-1286. PubMed ID: 34964243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarker Landscape in RASopathies.
    Ferrito N; Báez-Flores J; Rodríguez-Martín M; Sastre-Rodríguez J; Coppola A; Isidoro-García M; Prieto-Matos P; Lacal J
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New prospectives on treatment opportunities in RASopathies.
    Gelb BD; Yohe ME; Wolf C; Andelfinger G
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):541-560. PubMed ID: 36533679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXI2: a possible gene contributing to ectodermal dysplasia.
    Kurban M; Zeineddine SB; Hamie L; Safi R; Abbas O; Kibbi AG; Bitar F; Nemer G
    Eur J Dermatol; 2017 Dec; 27(6):641-645. PubMed ID: 29165300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.
    Bezniakow N; Gos M; Obersztyn E
    Dev Period Med; 2014; 18(3):285-96. PubMed ID: 25182392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Craniofacial and dental development in Costello syndrome.
    Goodwin AF; Oberoi S; Landan M; Charles C; Massie JC; Fairley C; Rauen KA; Klein OD
    Am J Med Genet A; 2014 Jun; 164A(6):1425-30. PubMed ID: 24668879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatological manifestations, management, and care in RASopathies.
    Kavamura MI; Leoni C; Neri G
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):452-458. PubMed ID: 36541891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Mutations Associated with Rasopathies in a Central European Population and Genotype-Phenotype Correlations.
    Čizmárová M; Hlinková K; Bertok S; Kotnik P; Duba HC; Bertalan R; Poločková K; Košťálová Ľ; Pribilincová Z; Hlavatá A; Kovács L; Ilenčíková D
    Ann Hum Genet; 2016 Jan; 80(1):50-62. PubMed ID: 26607044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
    Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
    Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.